Skip to main content
OpenTrials
Completed

NCT Number: NCT07759713

Varicocelectomy for Cryptozoospermic Men.

Patient Information leaflet on varicoceles surgery

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Andrology department

Qina, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male Infertility with cryptozoospermia and clinical varicoceles

Exclusion criteria

  • Genetic abnormalities. Other causes of male infertility

Treatment and study plan

Varicoceles ligation

Procedure

Microscopic surgery

Primary outcomes

  1. Semen

    Time frame: 12 months

    Improvement in the semen concentration (measured by million/ml). This will be checked by repeat semen analysis 6 and 12 months in both study groups.

Secondary outcomes

  1. IVF/pregnancy outcomes

    Time frame: 12 months

    • The percentage of biological pregnancy (The number of biological pregnancy/total patients) In both groups.
    • The percentage of live births (the Number of live birth/total number of patients) in both groups.

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

Varicocelectomy Versus Antioxidant Medication for Cryptozoospermic Men, A Prospective Randomized Trial

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Aug 12, 2026
Registry last updated
Aug 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.